{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:23Z","timestamp":1762867103519},"reference-count":61,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cjca.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T02:49:24Z","timestamp":1490410164000},"page":"1091-1098","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Economics of Transcatheter Valve Interventions"],"prefix":"10.1016","volume":"33","author":[{"given":"Maneesh","family":"Sud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick Y.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harindra C.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2017.03.015_bib1","series-title":"Diffusion of Innovations","author":"Rogers","year":"1962"},{"key":"10.1016\/j.cjca.2017.03.015_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cjca.2014.03.005","article-title":"Cost-effectiveness considerations in transcatheter management of valvular heart disease","volume":"30","author":"Gadey","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib3","doi-asserted-by":"crossref","unstructured":"Taramasso M, Pozzoli A, Guidotti A, et\u00a0al. Percutaneous tricuspid valve therapies: the new frontier [e-pub ahead of print]. Eur Heart J pii: ehv766.","DOI":"10.1093\/eurheartj\/ehv766"},{"key":"10.1016\/j.cjca.2017.03.015_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jval.2012.10.010","article-title":"Mapping to obtain EQ-5D utility values for use in NICE health technology assessments","volume":"16","author":"Longworth","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.cjca.2017.03.015_bib5","series-title":"Guidelines for the economic evaluation of health technologies: Canada","year":"2006"},{"key":"10.1016\/j.cjca.2017.03.015_bib6","series-title":"Methods for The Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.cjca.2017.03.015_bib7","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIR.0000000000000042","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"129","author":"Anderson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.03.015_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cjca.2015.04.033","article-title":"Transcatheter aortic valve implantation: current and evolving indications","volume":"32","author":"Yousef","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib9","doi-asserted-by":"crossref","first-page":"1038.e1","DOI":"10.1016\/j.cjca.2015.11.008","article-title":"Quality of care for transcatheter aortic valve implantation: development of Canadian Cardiovascular Society quality indicators","volume":"32","author":"Asgar","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.03.015_bib11","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.03.015_bib12","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/CIRCULATIONAHA.111.040022","article-title":"Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis","volume":"124","author":"Reynolds","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.03.015_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jtcvs.2012.06.018","article-title":"Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective","volume":"146","author":"Doble","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib14","first-page":"566","article-title":"Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER trial cohort B findings","volume":"16","author":"Hancock-Howard","year":"2013","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2017.03.015_bib15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.111.054072","article-title":"Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort B)","volume":"125","author":"Reynolds","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.03.015_bib16","first-page":"1","article-title":"Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update","volume":"13","author":"Sehatzadeh","year":"2013","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.cjca.2017.03.015_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCOUTCOMES.113.000280","article-title":"Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis","volume":"6","author":"Simons","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2017.03.015_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1586\/erd.12.53","article-title":"Edwards SAPIEN and Edwards SAPIEN XT transcatheter heart valves for the treatment of severe aortic stenosis","volume":"9","author":"Freeman","year":"2012","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.cjca.2017.03.015_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0266462312000670","article-title":"Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom","volume":"29","author":"Murphy","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.cjca.2017.03.015_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001032","article-title":"A\u00a0cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population","volume":"2","author":"Neyt","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2017.03.015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17330","article-title":"Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation","volume":"17","author":"Orlando","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.cjca.2017.03.015_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2011-300444","article-title":"Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement","volume":"98","author":"Watt","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2017.03.015_bib23","first-page":"213","article-title":"Transcatheter aortic valve implantation for the treatment of severe aortic valve stenosis in inoperable patients under the perspective of the Brazilian private healthcare system\u2014cost-effectiveness analysis","volume":"21","author":"Queiroga","year":"2013","journal-title":"Rev Bras Cardiol Invasiva"},{"key":"10.1016\/j.cjca.2017.03.015_bib24","doi-asserted-by":"crossref","first-page":"A1727","DOI":"10.1016\/S0735-1097(15)61727-2","article-title":"Costs and in-hospital outcomes of transcatheter versus surgical aortic valve replacement in commercial cases using a propensity score matched model","volume":"1","author":"Minutello","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5830\/CVJA-2013-090","article-title":"An analysis of real-world cost-effectiveness of TAVI in South Africa","volume":"25","author":"Mabin","year":"2014","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.cjca.2017.03.015_bib26","doi-asserted-by":"crossref","first-page":"e000155","DOI":"10.1136\/openhrt-2014-000155","article-title":"Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study","volume":"1","author":"Brecker","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.cjca.2017.03.015_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jtcvs.2012.09.038","article-title":"Correction of faulty assumptions in cost-effectiveness analysis","volume":"145","author":"Reynolds","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2013.08.1641","article-title":"Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons","volume":"63","author":"Makkar","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib29","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.03.015_bib30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.03.015_bib31","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jcin.2015.04.018","article-title":"Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: results from the CoreValve US pivotal trial","volume":"8","author":"Arnold","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2017.03.015_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jacc.2012.03.075","article-title":"Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (cohort A)","volume":"60","author":"Reynolds","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.athoracsur.2015.05.125","article-title":"Transcatheter aortic valve replacement versus aortic valve bypass: a comparison of outcomes and economics","volume":"101","author":"Brown","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/heartjnl-2013-303722","article-title":"The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk","volume":"99","author":"Fairbairn","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2017.03.015_bib35","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.amjcard.2011.12.030","article-title":"Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients","volume":"109","author":"Gada","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2015.10.046","article-title":"Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement","volume":"67","author":"Reynolds","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.amjcard.2015.08.043","article-title":"Clinical outcome and cost analysis of sutureless versus transcatheter aortic valve implantation with propensity score matching analysis","volume":"116","author":"Santarpino","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib38","first-page":"145","article-title":"Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model","volume":"1","author":"Gada","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2014.12.109","article-title":"Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants","volume":"182","author":"Ribera","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib40","first-page":"1","article-title":"Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment","volume":"16","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.cjca.2017.03.015_bib41","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2012.09.018","article-title":"Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (cohort A)","volume":"60","author":"Reynolds","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCOUTCOMES.115.002541","article-title":"Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay","volume":"9","author":"Lauck","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2017.03.015_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCINTERVENTIONS.114.001395","article-title":"Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial","volume":"7","author":"Arnold","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2017.03.015_bib44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.03.015_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.athoracsur.2015.05.120","article-title":"Contemporary costs associated with transcatheter aortic valve replacement: a propensity-matched cost analysis","volume":"101","author":"Ailawadi","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.athoracsur.2012.07.002","article-title":"Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients","volume":"94","author":"Osnabrugge","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjca.2017.03.015_bib47","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1161\/CIR.0000000000000031","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.03.015_bib48","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2017.03.015_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2013.08.723","article-title":"Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need","volume":"63","author":"Goel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib50","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.03.015_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study","volume":"59","author":"Whitlow","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jcin.2014.01.171","article-title":"Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients","volume":"7","author":"Swaans","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2017.03.015_bib53","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ahj.2015.08.004","article-title":"The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison","volume":"170","author":"Velazquez","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2017.03.015_bib54","first-page":"599","article-title":"A\u00a0Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in patients at high surgical risk with significant mitral regurgitation","volume":"17","author":"Cameron","year":"2014","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2017.03.015_bib55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2016.01.212","article-title":"Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation","volume":"209","author":"Armeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2017.03.015_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12872-015-0039-8","article-title":"Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings","volume":"15","author":"Borisenko","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2017.03.015_bib57","first-page":"696","article-title":"MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option","volume":"19","author":"Guerin","year":"2016","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2017.03.015_bib58","first-page":"1317","article-title":"EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip(R) in patients with severe mitral regurgitation ineligible for conventional repair\/replacement surgery","volume":"16","author":"Mealing","year":"2013","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2017.03.015_bib59","first-page":"89","article-title":"Impact of DRG billing system on health budget consumption in percutaneous treatment of mitral valve regurgitation in heart failure","volume":"18","author":"Palmieri","year":"2015","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2017.03.015_bib60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/eurjhf\/hfs076","article-title":"Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial","volume":"14","author":"Siminiak","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2017.03.015_bib61","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jacc.2014.06.1208","article-title":"Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation","volume":"64","author":"Cheung","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1730137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1730137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T05:18:35Z","timestamp":1568956715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1730137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0828282X1730137X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2017.03.015","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Economics of Transcatheter Valve Interventions","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}